DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR MALIGNANT AND BENIGN BREAST PATHOLOGY Russian patent published in 2014 - IPC G01N33/533 

FIELD: medicine.

SUBSTANCE: peripheral blood dead cells are treated with primary oestrogen-binding protein antibodies specifically interacting with segmented granulocyte superficial antigens; secondary anti-species fluorescent-labelled antibodies are added to the antigen-antibody complex; the malignant new growths are diagnosed if the segmented granulocyte surface is reported to be stained; no dye stains on the segmented granulocyte surface enable diagnosing benign new growths. The method is non-invasive, enables fast and 100%-accurate differentiation of the patients suffering from breast cancer and the patients with benign new growths and healthy women.

EFFECT: lower self-discharge, higher efficiency with an increased power density per a unit of weight; the test can be used for the instant diagnosis of breast cancer.

6 ex, 6 dwg